首页> 外文期刊>Immunology: An Official Journal of the British Society for Immunology >Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
【24h】

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.

机译:关节炎患者滑液天然杀伤细胞上的激活受体和抑制受体:CD94 / NKG2A在控制细胞因子分泌中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Natural killer (NK) cells are activated early during inflammatory events and contribute to the shaping of the ensuing adaptive immune response. To further understand the role for NK cells in inflammation, we investigated the phenotype and function of synovial fluid (SF) NK cells from patients with chronic joint inflammation, as well as from patients with transient inflammation of the knee following trauma. We confirm that synovial NK cells are similar to the well-characterized CD56(bright) peripheral blood (PB) NK-cell subset present in healthy individuals. However, compared to this PB subset the synovial NK cells express a higher degree of activation markers including CD69 and NKp44, the latter being up-regulated also on CD56(bright) NK cells in the PB of patients. Activated synovial NK cells produced interferon-gamma and tumour necrosis factor, and the production was further up-regulated by antibody masking of CD94/NKG2A, and down-regulated by target cells expressing human leucocyte antigen-E in complex with peptides known to engage CD94/NKG2A. We conclude that synovial NK cells have an activated phenotype and that CD94/NKG2A is a key regulator of synovial NK-cell cytokine synthesis.
机译:天然杀伤(NK)细胞在炎症事件早期被激活,并有助于随后的适应性免疫应答的形成。为了进一步了解NK细胞在炎症中的作用,我们研究了慢性关节发炎患者以及膝关节短暂性炎症患者滑膜液(SF)NK细胞的表型和功能。我们确认滑膜NK细胞类似于健康个体中特征明确的CD56(明亮)外周血(PB)NK细胞亚群。然而,与该PB子集相比,滑膜NK细胞表达更高水平的活化标记,包括CD69和NKp44,后者在患者PB中的CD56(亮)NK细胞上也被上调。激活的滑膜NK细胞产生干扰素-γ和肿瘤坏死因子,并且通过CD94 / NKG2A的抗体掩蔽进一步上调该产生,并通过与已知与CD94结合的肽复合表达人白细胞抗原-E的靶细胞下调其产生。 / NKG2A。我们得出结论,滑膜NK细胞具有激活的表型,并且CD94 / NKG2A是滑膜NK细胞细胞因子合成的关键调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号